DANTRIUM

This brand name is authorized in United States. It is also authorized in Australia, Canada, Estonia, France, Ireland, Japan, Malta, Netherlands, New Zealand, Romania, South Africa, UK.

Active ingredients

The drug DANTRIUM contains one active pharmaceutical ingredient (API):

1	Dantrolene UNII 287M0347EV - DANTROLENE SODIUM
	The receptor molecule for dantrolene has not been identified. Dantrolene inhibits the binding of ryanodine. Under some conditions, dantrolene will lower intra-sarcoplasmic calcium concentrations in the resting state. This may be more important in diseased muscle (e.g. In malignant hyperthermia in humans and swine stress syndrome) than in muscle with normal function.
	Read more about Dantrolene

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DANTRIUM Capsules	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
DANTRIUM Powder for solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M03CA01	Dantrolene	M Musculo-skeletal system → M03 Muscle relaxants → M03C Muscle relaxants, directly acting agents → M03CA Dantrolene and derivatives
Discover more medicines within M03CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1779P, 1780Q
CA	Health Products and Food Branch	01997572, 01997602
EE	Ravimiamet	1790333
FR	Base de données publique des médicaments	60385682, 65074386, 67807645
GB	Medicines & Healthcare Products Regulatory Agency	142199, 161561, 182475, 182476, 185725, 197460, 26174, 26182, 43539
IE	Health Products Regulatory Authority	66443, 66451
JP	医薬品医療機器総合機構	1229002M1036
MT	Medicines Authority	AA729/27701, AA729/27702
NL	Z-Index G-Standaard	13516132
NL	Z-Index G-Standaard, PRK	29335, 3204
NZ	Medicines and Medical Devices Safety Authority	10635, 10636, 2297
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68769001
US	FDA, National Drug Code	42023-123, 42023-124, 42023-125
ZA	Health Products Regulatory Authority	H/17.1/64, H/17.1/65, M/17.1/0253